The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...
Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...
New research has examined how accurate continuous glucose monitors (CGM) are in comparison to capillary blood glucose ...
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
President Donald Trump announced Thursday that CMA CGM would pour billions of dollars' worth of funds into the U.S. economy ...
Senseonics Holdings, Inc. ( NYSE: SENS) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Jeremy Feffer - Investor Relations, LifeSci Advisors Tim Goodnow - President and Chief Executive ...
Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...
Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.
such as data from CGMs and insulin pumps, with wrap-around clinical support services. SweetSpot’s virtual team of Certified Diabetes Care and Education Specialists (CDCES) perform monthly CGM ...
SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care. SweetSpot combines a centralized software platform for managing diabetes device data, such ...
The trial compared use of a t:slim X2 pump with Control-IQ+ technology to a control group who continued their existing multiple daily injections regimens. Both groups used a Dexcom G6 Continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results